173 related articles for article (PubMed ID: 38341600)
1. Sacubitril/valsartan ameliorates tubulointerstitial fibrosis by restoring mitochondrial homeostasis in diabetic kidney disease.
Zhang XJ; Liu CC; Li ZL; Ding L; Zhou Y; Zhang DJ; Zhang Y; Hou ST; Ma RX
Diabetol Metab Syndr; 2024 Feb; 16(1):40. PubMed ID: 38341600
[TBL] [Abstract][Full Text] [Related]
2. Sacubitril/Valsartan contributes to improving the diabetic kidney disease and regulating the gut microbiota in mice.
Wang P; Guo R; Bai X; Cui W; Zhang Y; Li H; Shang J; Zhao Z
Front Endocrinol (Lausanne); 2022; 13():1034818. PubMed ID: 36589853
[TBL] [Abstract][Full Text] [Related]
3. Sacubitril/valsartan ameliorates renal tubulointerstitial injury through increasing renal plasma flow in a mouse model of type 2 diabetes with aldosterone excess.
Nishio H; Ishii A; Yamada H; Mori KP; Kato Y; Ohno S; Handa T; Sugioka S; Ishimura T; Ikushima A; Inoue Y; Minamino N; Mukoyama M; Yanagita M; Yokoi H
Nephrol Dial Transplant; 2023 Oct; 38(11):2517-2527. PubMed ID: 37202215
[TBL] [Abstract][Full Text] [Related]
4. ATF5 regulates tubulointerstitial injury in diabetic kidney disease via mitochondrial unfolded protein response.
Liu Y; Zhang L; Zhang S; Liu J; Li X; Yang K; Yang D; Liu Y; Sun L; Liu F; Xiao L
Mol Med; 2023 Apr; 29(1):57. PubMed ID: 37095454
[TBL] [Abstract][Full Text] [Related]
5. The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat.
Habibi J; Aroor AR; Das NA; Manrique-Acevedo CM; Johnson MS; Hayden MR; Nistala R; Wiedmeyer C; Chandrasekar B; DeMarco VG
Cardiovasc Diabetol; 2019 Mar; 18(1):40. PubMed ID: 30909895
[TBL] [Abstract][Full Text] [Related]
6. Sacubitril/valsartan treatment has differential effects in modulating diabetic kidney disease in
Myakala K; Jones BA; Wang XX; Levi M
Am J Physiol Renal Physiol; 2021 Jun; 320(6):F1133-F1151. PubMed ID: 33870733
[TBL] [Abstract][Full Text] [Related]
7. FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease.
Huang F; Wang Q; Guo F; Zhao Y; Ji L; An T; Song Y; Liu Y; He Y; Qin G
EBioMedicine; 2019 Oct; 48():491-504. PubMed ID: 31629675
[TBL] [Abstract][Full Text] [Related]
8. Tubular TMEM16A promotes tubulointerstitial fibrosis by suppressing PGC-1α-mediated mitochondrial homeostasis in diabetic kidney disease.
Ji JL; Li JY; Liang JX; Zhou Y; Liu CC; Zhang Y; Zhang AQ; Liu H; Ma RX; Li ZL
Cell Mol Life Sci; 2023 Nov; 80(12):347. PubMed ID: 37943391
[TBL] [Abstract][Full Text] [Related]
9. Huangkui capsule attenuates diabetic kidney disease through the induction of mitophagy mediated by STING1/PINK1 signaling in tubular cells.
Zhu Z; Luan G; Peng S; Fang Y; Fang Q; Shen S; Wu K; Qian S; Jia W; Ye J; Wei L
Phytomedicine; 2023 Oct; 119():154975. PubMed ID: 37517171
[TBL] [Abstract][Full Text] [Related]
10. PGC-1α ameliorates kidney fibrosis in mice with diabetic kidney disease through an antioxidative mechanism.
Zhang L; Liu J; Zhou F; Wang W; Chen N
Mol Med Rep; 2018 Mar; 17(3):4490-4498. PubMed ID: 29344670
[TBL] [Abstract][Full Text] [Related]
11. IL-37 Ameliorates Renal Fibrosis by Restoring CPT1A-Mediated Fatty Acid Oxidation in Diabetic Kidney Disease.
Xiong L; He T; Liu C; Qin S; Xiao T; Xin W; Wang Y; Ran L; Zhang B; Zhao J
Kidney Dis (Basel); 2023 Apr; 9(2):104-117. PubMed ID: 37065609
[TBL] [Abstract][Full Text] [Related]
12. [1, 25-(OH)
Huang C; Dong R; Li Z; Yuan J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Apr; 39(4):325-331. PubMed ID: 37087550
[TBL] [Abstract][Full Text] [Related]
13. Baicalin ameliorates renal fibrosis by upregulating CPT1α-mediated fatty acid oxidation in diabetic kidney disease.
Hu H; Li W; Hao Y; Peng Z; Zou Z; Liang W
Phytomedicine; 2024 Jan; 122():155162. PubMed ID: 37922789
[TBL] [Abstract][Full Text] [Related]
14. Strain-selective efficacy of sacubitril/valsartan on carotid fibrosis in response to injury in two inbred mouse strains.
Korshunov VA; Quinn B; Faiyaz A; Ahmed R; Sowden MP; Doyley MM; Berk BC
Br J Pharmacol; 2019 Aug; 176(15):2795-2807. PubMed ID: 31077344
[TBL] [Abstract][Full Text] [Related]
15. Placental Mesenchymal Stem Cells Alleviate Podocyte Injury in Diabetic Kidney Disease by Modulating Mitophagy via the SIRT1-PGC-1alpha-TFAM Pathway.
Han X; Wang J; Li R; Huang M; Yue G; Guan L; Deng Y; Cai W; Xu J
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902127
[TBL] [Abstract][Full Text] [Related]
16. Sacubitril/Valsartan Reduces Fibrosis and Alleviates High-Salt Diet-Induced HFpEF in Rats.
Zhang W; Liu J; Fu Y; Ji H; Fang Z; Zhou W; Fan H; Zhang Y; Liao Y; Yang T; Wang X; Yuan W; Chen X; Dong YF
Front Pharmacol; 2020; 11():600953. PubMed ID: 33519461
[TBL] [Abstract][Full Text] [Related]
17. Aspirin mediates protection from diabetic kidney disease by inducing ferroptosis inhibition.
Wu Z; Li D; Tian D; Liu X; Wu Z
PLoS One; 2022; 17(12):e0279010. PubMed ID: 36516169
[TBL] [Abstract][Full Text] [Related]
18. Protection of Sacubitril/Valsartan against Pathological Cardiac Remodeling by Inhibiting the NLRP3 Inflammasome after Relief of Pressure Overload in Mice.
Li X; Zhu Q; Wang Q; Zhang Q; Zheng Y; Wang L; Jin Q
Cardiovasc Drugs Ther; 2020 Oct; 34(5):629-640. PubMed ID: 32444995
[TBL] [Abstract][Full Text] [Related]
19. Dendrobium officinale Kimura & Migo polysaccharide inhibits hyperglycaemia-induced kidney fibrosis via the miRNA-34a-5p/SIRT1 signalling pathway.
Huang C; Yu J; Da J; Dong R; Dai L; Yang Y; Deng Y; Yuan J
J Ethnopharmacol; 2023 Sep; 313():116601. PubMed ID: 37146843
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney Disease.
Hu Y; Tang W; Liu W; Hu Z; Pan C
Drug Des Devel Ther; 2022; 16():1605-1620. PubMed ID: 35669284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
